Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

BioIson Unlocking Fe(II)/αKG-dioxygenase enzymes as sustainable biocatalysts for the synthesis of isonitriles

Coordinator
University College London, United Kingdom
Runs
1 September 2026 to 31 August 2028
Status
Running
EU funding
€260k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101208178

What the project is doing

In the project's own words, from its summary on CORDIS.

Isonitriles are valuable organic molecules endowed with unique reactivity features, which find wide applications in a variety of chemical fields, from material sciences to chemical biology, organic, and medicinal chemistry. Current methods to prepare isonitriles suffer from major drawbacks in terms of safety and sustainability, as they rely on the use of large amounts of highly toxic chemicals (e.g., COCl2, POCl3, TMSCN), which make their synthesis hazardous and wasteful, especially for industrial-scale production.

Based on the established ability of biocatalytic strategies to enable milder, greener, and more selective chemical processes, the aim of this project is to investigate, characterise, and engineer the protein ScoE from Streptomyces coeruleorubidus and related isonitrile-forming enzymes from the Fe(II)/KG-dioxygenase superfamily with the final goal to turn them into a new class of biocatalysts for the sustainable production of isonitrile compounds.

The project will first characterise wild-type ScoE in order to optimise the biotransformation parameters and to evaluate the in vitro catalytic performances of the enzyme and its natural substrate scope (specificity and selectivity). In parallel, representative isonitrile-forming Fe(II)/KG-dioxygenases with potential for different activity and selectivity will be selected from assorted environmental niches and assessed for their substrate flexibility and their ability to biocatalyse the synthesis of isonitrile derivatives in vitro.

Such investigations will provide experimental data to drive the identification of best candidates for biocatalyst development. Mutagenesis studies driven by in-silico design will be performed to generate improved Fe(II)/KG-dioxygenase variants (with broader substrate scope) to be exploited as biocatalysts. The hit enzymes will be produced on larger scale and biocatalytic methods for the preparative synthesis of isonitriles will be developed.

Topics

Who is involved

OrganisationCityCountryRole
University College LondonLondonUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI